GNMX Corgi Genomics & Precision Medicine ETF

ETF

ETF quote, holdings, sector allocation, technicals, and options analytics. Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

GNMX — —
Key stats
About

Corgi Genomics & Precision Medicine ETF (GNMX) ETF

No description available.

Exchange
BATS
Inception
2026-05-05
Has Options
No
Fund profile
holdings as of Oct 23, 2026issuer datathrough Jun 2026flows, SEC filings
Thematic Biotech & Health Innovation#23 of 26 by assets Corgi US
Expense ratio
0.35%
issuer, Oct 26, 2026
Assets
$1.3M
issuer-reported, Oct 23, 2026
Trailing yield
—
Average daily volume
$116K
30 sessions
Holdings
59
top 10 are 48.2%
Listed
May 5, 2026
Cboe BZX
Net asset value
$36.56
issuer, Oct 23, 2026 · closed +0.10% to NAV
30-day SEC yield
-0.21%
issuer
Closure risk, 12 months
7.6%
low: trading volume, age, volatility · model
FrenzyCap ETF score
42
how it is built
Cost86
Liquidity2
Scale0
Diversification56

Stated objective. "The Corgi Genomics & Precision Medicine ETF (the ""Fund"") seeks capital appreciation." (from the fund's prospectus)

All 59 holdingsFlow historySimilar fundsOverlap toolAll Biotech & Health Innovation ETFs

Fund flows
through Jun 2026SEC filings
Jun 2026
$0
latest reported month
Latest 3 months
+$1.3M
+74.7% of assets
Latest 12 months
—
May 2026: +$1.3M+$1.3MMayJun 2026: $0Jun
View as a table
Net flows of GNMX by month, May 2026 to Jun 2026
MonthNet flow
Jun 2026$0
May 2026+$1.3M

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 2 months ago

Similar funds
FundOverlapFeeAssets1Y
GNOMGlobal X Genomics & Biotechnology ETF47%0.50%$105M+52.6%compare
IDNAiShares Genomics Immunology and Healthcare ETF33%0.47%$321M+66.6%compare
ARKGARK Genomic Revolution ETF33%0.75%$1.9B+57.5%compare
IBBiShares Biotechnology ETF31%0.44%$10.7B+35.0%compare
BBHVanEck Biotech ETF31%0.35%$502M+39.0%compare

Ranked by how much of the two portfolios is the same securities.

Look-through: what the holdings say
weights as of Oct 23, 2026issuer data
Holdings vs fair value
+4.7%
25% under, 36% over · 99% covered
Price / earnings
—
59% loss-making · 93% covered
Price / book · sales
4.5 · 7.2
revenue growth +8.9%
Above 200-day average
86%
58% above 50-day · by weight
Short interest
11.1%
of float, weighted · 4.5 days to cover
Insider buying
3%
of weight had net insider buying, 90 days; 60% net selling
13F holders
−0.1%
change in shares held by institutions, latest quarter
Reporting earnings
26.7%
of weight in 7 days; 83.7% in 14
Largest contributors below fair value
INCY+50%BMRN+50%NEO+50%NRIX+50%CRSP+48%
Largest contributors above fair value
MRNA−11%ILMN−19%IOVA−17%TXG−16%GMAB−13%

Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.

ETF Profile
holdings as of 2026-10-26
Holdings
59
AUM
$1.3M
Provider
Corgi
Inception
2026-05-05
Exchange
BATS
Data As Of
2026-10-26
Expense Ratio
0.35%
Dividend Yield
—
Distribution
Annual
Asset Allocation
Top Holdings
top 50 of 59 holdings
Symbol Name Weight % Asset Class Country
MRNA Moderna Inc 8.97% Equity (US) US
TMO Thermo Fisher Scientific Inc 8.94% Equity (US) US
VRTX Vertex Pharmaceuticals Inc 5.91% Equity (US) US
ILMN Illumina Inc 4.86% Equity (US) US
GMAB Genmab A/S 3.69% Equity (Foreign) DK
GH Guardant Health Inc 3.67% Equity (US) US
TXG 10X Genomics Inc 3.21% Equity (US) US
RVMD Revolution Medicines Inc 3.10% Equity (US) US
IOVA Iovance Biotherapeutics Inc 3.05% Equity (US) US
INCY Incyte Corp 2.59% Equity (US) US
— First American Government Obligations Fund 12/01/2031 2.58% Cash/Money Market —
ALNY Alnylam Pharmaceuticals Inc 2.48% Equity (US) US
TWST Twist Bioscience Corp 2.45% Equity (US) US
GRAL GRAIL Inc 2.28% Equity (US) US
TECH Bio-Techne Corp 2.17% Equity (US) US
QGEN QIAGEN NV 2.14% Equity (Foreign) NL
CDNA CareDx Inc 2.03% Equity (US) US
BMRN BioMarin Pharmaceutical Inc 1.91% Equity (US) US
TEM Tempus AI Inc 1.72% Equity (US) US
KRYS Krystal Biotech Inc 1.71% Equity (US) US
ADPT Adaptive Biotechnologies Corp 1.69% Equity (US) US
CAI Caris Life Sciences Inc 1.41% Equity (US) US
VCYT Veracyte Inc 1.39% Equity (US) US
NEO NeoGenomics Inc 1.32% Equity (US) US
ARWR Arrowhead Pharmaceuticals Inc 1.31% Equity (US) US
CRSP CRISPR Therapeutics AG 1.25% Equity (US) US
NRIX Nurix Therapeutics Inc 1.25% Equity (US) US
PSNL Personalis Inc 1.23% Equity (US) US
SDGR Schrodinger Inc/United States 1.21% Equity (US) US
IONS Ionis Pharmaceuticals Inc 1.13% Equity (US) US
IDYA Ideaya Biosciences Inc 1.11% Equity (US) US
ABSI Absci Corp 1.11% Equity (US) US
RLAY Relay Therapeutics Inc 0.99% Equity (US) US
CERT Certara Inc 0.95% Equity (US) US
AZTA Azenta Inc 0.91% Equity (US) US
RXRX Recursion Pharmaceuticals Inc 0.88% Equity (US) US
BEAM Beam Therapeutics Inc 0.83% Equity (US) US
SRPT Sarepta Therapeutics Inc 0.82% Equity (US) US
QURE uniQure NV 0.80% Equity (Foreign) NL
CSTL Castle Biosciences Inc 0.76% Equity (US) US
WGS GeneDx Holdings Corp 0.67% Equity (US) US
PACB Pacific Biosciences of California Inc 0.65% Equity (US) US
NTLA Intellia Therapeutics Inc 0.65% Equity (US) US
RARE Ultragenyx Pharmaceutical Inc 0.59% Equity (US) US
SOPH Sophia Genetics SA 0.58% Equity (Foreign) CH
FDMT 4D Molecular Therapeutics Inc 0.57% Equity (US) US
MYGN Myriad Genetics Inc 0.57% Equity (US) US
GENB Generate Biomedicines Inc 0.56% Equity (US) US
FLGT Fulgent Genetics Inc 0.52% Equity (US) US
BDSX Biodesix Inc 0.49% Equity (US) US
Geographic Breakdown
Chart
Seasonality
'26Avg
Jan----
Feb----
Mar----
Apr----
May5.02%5.02%
Jun16.54%16.54%
Jul-5.79%-5.79%
Aug16.98%16.98%
Sep9.04%9.04%
Oct-1.49%*-1.49%
Nov----
Dec----
Total44.88%44.88%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $37.08
SMA 50: $36.19
SMA 200: —
Current: $36.79
EMA 12: $36.84
EMA 26: $36.66
MACD: 0.1806 | Signal: -0.1213
BULLISH
ADX (14): 22.13
WEAK TREND
+DI: 37.73
−DI: 33.05

Momentum Oscillators

RSI (14): 50.89
NEUTRAL
Stoch %K: 33.51
Stoch %D: 37.60
Williams %R: -50.37

Volume & Volatility

BB Upper: $38.84
BB Lower: $35.32
NEUTRAL
OBV: 29,153
Vol SMA 20: 4,170
Vol ROC: -79.47%
ATR: $0.84
True Range: $0.19
HV 20: 42.8%
HV 30: 39.1%
HV 60: 39.1%

Data Summary

Data Points: 120
Last Updated:
Date Range: 2026-05-06T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All GNMX news →

GNMX Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 1.0167
Alpha: 71.99%
Correlation: 0.3567
R-Squared: 12.7%
Stock Volatility: 34.3%
Market Volatility: 12.0%

Analysis Details

Benchmark: SPY
Data Points: 119
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time

GNMX Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

1 filers12,435 shares$386.58K value
# Filer Shares Value % of Total % of Float Period
1 GTS SECURITIES LLC 12,435 $386.58K 100.00% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
GNMX Constituent Performance

Click any bar to view the full quote for that stock.

GNMX Constituents (57 of 57)
Symbol Name Weight % Price 1 Day 1 Week 1 Month
MRNA Moderna Inc 8.97% $198.85 -0.62%-12.36%+0.80%
TMO Thermo Fisher Scientific Inc 8.94% $684.89 +1.64%+0.81%+0.93%
VRTX Vertex Pharmaceuticals Inc 5.91% $517.49 -1.23%+3.10%-1.93%
ILMN Illumina Inc 4.86% $271.04 +0.60%+3.19%-0.32%
GMAB Genmab A/S 3.69% $44.69 +2.04%+16.06%+26.37%
GH Guardant Health Inc 3.67% $173.25 +2.47%+9.74%-2.30%
TXG 10X Genomics Inc 3.21% $72.96 +1.97%+4.39%-17.56%
RVMD Revolution Medicines Inc 3.10% $183.9 -1.65%+0.96%-8.84%
IOVA Iovance Biotherapeutics Inc 3.05% $13.78 -2.20%-3.03%+25.39%
INCY Incyte Corp 2.59% $113.31 -2.07%+0.05%-9.22%
ALNY Alnylam Pharmaceuticals Inc 2.48% $227.66 +1.62%-2.41%-10.85%
TWST Twist Bioscience Corp 2.45% $145.25 +3.81%+3.92%-19.13%
GRAL GRAIL Inc 2.28% $139.91 +5.55%+14.29%+5.49%
TECH Bio-Techne Corp 2.17% $72.69 +0.19%+0.28%+0.25%
QGEN QIAGEN NV 2.14% $50.37 -0.04%+8.21%+11.91%
CDNA CareDx Inc 2.03% $69.1 -0.16%+3.01%+6.97%
BMRN BioMarin Pharmaceutical Inc 1.91% $55.75 -0.36%+1.98%-6.24%
TEM Tempus AI Inc 1.72% $67.16 -0.67%+4.38%-21.06%
KRYS Krystal Biotech Inc 1.71% $313.66 +0.69%-2.06%-6.95%
ADPT Adaptive Biotechnologies Corp 1.69% $26.27 +2.98%+9.69%-7.86%
CAI Caris Life Sciences Inc 1.41% $32.45 +1.42%+5.68%+2.22%
VCYT Veracyte Inc 1.39% $48.2 +0.56%+10.05%+6.57%
NEO NeoGenomics Inc 1.32% $16.69 +0.60%+1.64%-13.48%
ARWR Arrowhead Pharmaceuticals Inc 1.31% $58.98 +1.65%+3.06%-9.90%
NRIX Nurix Therapeutics Inc 1.25% $25.55 +0.83%+2.49%+7.94%
CRSP CRISPR Therapeutics AG 1.25% $49.01 -0.77%-2.06%-9.39%
PSNL Personalis Inc 1.23% $15.88 +0.19%+0.00%-2.70%
SDGR Schrodinger Inc/United States 1.21% $24.5 +2.94%+5.97%-16.95%
IONS Ionis Pharmaceuticals Inc 1.13% $43.42 +1.14%-2.16%-4.72%
ABSI Absci Corp 1.11% $9.45 +2.94%+10.66%-0.42%
IDYA Ideaya Biosciences Inc 1.11% $32.88 -5.27%-2.75%-13.97%
RLAY Relay Therapeutics Inc 0.99% $18.12 -0.33%+6.03%+2.43%
CERT Certara Inc 0.95% $10.61 +2.71%+12.28%+16.21%
AZTA Azenta Inc 0.91% $37.17 +1.84%+6.69%+8.53%
RXRX Recursion Pharmaceuticals Inc 0.88% $3.8 +2.70%+5.26%+2.70%
BEAM Beam Therapeutics Inc 0.83% $23.79 -1.08%-1.65%-1.82%
SRPT Sarepta Therapeutics Inc 0.82% $17.98 +1.41%+1.41%-4.36%
QURE uniQure NV 0.80% $21.65 -3.48%-2.48%-44.64%
CSTL Castle Biosciences Inc 0.76% $33.3 +0.67%+3.53%-7.32%
WGS GeneDx Holdings Corp 0.67% $61.26 +9.10%-7.59%-28.71%
PACB Pacific Biosciences of California Inc 0.65% $2.25 +6.64%+22.28%+31.58%
NTLA Intellia Therapeutics Inc 0.65% $11.26 +0.45%-2.76%-1.40%
RARE Ultragenyx Pharmaceutical Inc 0.59% $16.08 +2.75%+6.70%+11.59%
SOPH Sophia Genetics SA 0.58% $7.52 +2.31%+15.87%-11.43%
MYGN Myriad Genetics Inc 0.57% $6.02 +3.44%+42.99%+41.98%
FDMT 4D Molecular Therapeutics Inc 0.57% $11.03 +2.13%-10.25%-24.24%
GENB Generate Biomedicines Inc 0.56% $12.35 -0.48%-1.67%-17.17%
FLGT Fulgent Genetics Inc 0.52% $20.22 +0.60%+0.60%-9.57%
BDSX Biodesix Inc 0.49% $21.26 +0.38%-9.15%-30.11%
PRME Prime Medicine Inc 0.43% $3.61 -1.63%-5.74%+25.57%